These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34455015)

  • 1. Chronic exposure to FGF2 converts iPSCs into cancer stem cells with an enhanced integrin/focal adhesion/PI3K/AKT axis.
    Sheta M; Hassan G; Afify SM; Monzur S; Kumon K; Abu Quora HA; Farahat M; Zahra MH; Fu X; Seno A; Seno M
    Cancer Lett; 2021 Aug; 521():142-154. PubMed ID: 34455015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis.
    Minematsu H; Afify SM; Sugihara Y; Hassan G; Zahra MH; Seno A; Adachi M; Seno M
    Sci Rep; 2022 Sep; 12(1):15628. PubMed ID: 36115905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 2 enhances BMSC stemness through ITGA2-dependent PI3K/AKT pathway activation.
    Jiang N; Hu Z; Wang Q; Hao J; Yang R; Jiang J; Wang H
    J Cell Physiol; 2024 Dec; 239(12):e31423. PubMed ID: 39188080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway.
    Hassan G; Afify SM; Du J; Nawara HM; Sheta M; Monzur S; Zahra MH; Abu Quora HA; Mansour H; El-Ghlban S; Uesaki R; Seno A; Seno M
    Biochem Biophys Res Commun; 2021 Oct; 583():49-55. PubMed ID: 34735879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
    Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
    PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
    Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
    J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
    Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
    Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment.
    Oo AKK; Calle AS; Nair N; Mahmud H; Vaidyanath A; Yamauchi J; Khayrani AC; Du J; Alam MJ; Seno A; Mizutani A; Murakami H; Iwasaki Y; Chen L; Kasai T; Seno M
    Transl Oncol; 2018 Jun; 11(3):653-663. PubMed ID: 29621663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.
    Hassan G; Afify SM; Zahra MH; Nawara HM; Kumon K; Iwasaki Y; Salomon DS; Seno A; Seno M
    Cytotechnology; 2023 Jun; 75(3):243-253. PubMed ID: 37181678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Localization of Fibroblast Growth Factor Receptor 1 in Breast Cancer Cells Interacting with Cancer Associated Fibroblasts.
    Suh J; Kim DH; Kim SJ; Cho NC; Lee YH; Jang JH; Surh YJ
    J Cancer Prev; 2022 Mar; 27(1):68-76. PubMed ID: 35419302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell induction from mouse embryonic stem cells.
    Seno A; Murakami C; El-Aarag B; Iwasaki Y; Ohara T; Seno M
    Oncol Lett; 2019 Sep; 18(3):2756-2762. PubMed ID: 31452753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironment of mammary fat pads affected the characteristics of the tumors derived from the induced cancer stem cells.
    Abu Quora HA; Zahra MH; El-Ghlban S; Nair N; Afify SM; Hassan G; Nawara HM; Sheta M; Monzur S; Fu X; Osman A; Seno A; Seno M
    Am J Cancer Res; 2021; 11(7):3475-3495. PubMed ID: 34354856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.
    Yang Y; Adachi K; Sheridan MA; Alexenko AP; Schust DJ; Schulz LC; Ezashi T; Roberts RM
    Proc Natl Acad Sci U S A; 2015 May; 112(18):E2337-46. PubMed ID: 25870291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells.
    Lehmann RJ; Jolly LA; Johnson BV; Lord MS; Kim HN; Saville JT; Fuller M; Byers S; Derrick-Roberts ALK
    Mol Genet Metab Rep; 2021 Dec; 29():100811. PubMed ID: 34712574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF2 and EGF Are Required for Self-Renewal and Organoid Formation of Canine Normal and Tumor Breast Stem Cells.
    Cocola C; Molgora S; Piscitelli E; Veronesi MC; Greco M; Bragato C; Moro M; Crosti M; Gray B; Milanesi L; Grieco V; Luvoni GC; Kehler J; Bellipanni G; Reinbold R; Zucchi I; Giordano A
    J Cell Biochem; 2017 Mar; 118(3):570-584. PubMed ID: 27632571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.